logo
Health Canada recalls baby nests sold under 'eleven' brand over strangulation and entrapment risks

Health Canada recalls baby nests sold under 'eleven' brand over strangulation and entrapment risks

Time of India03-08-2025
Synopsis
Health Canada has recalled 3,007 BChic and Chicure model baby nests sold under the 'eleven' brand due to fall, strangulation, and entrapment hazards. Sold between February 2020 and July 2025, these soft, fabric-lined nests pose a risk to infants. Consumers are urged to stop using them immediately and dispose of them safely.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Merck KGaA Second Quarter 2025 Earnings: Misses Expectations
Merck KGaA Second Quarter 2025 Earnings: Misses Expectations

Yahoo

time2 minutes ago

  • Yahoo

Merck KGaA Second Quarter 2025 Earnings: Misses Expectations

Explore Merck KGaA's Fair Values from the Community and select yours Merck KGaA (ETR:MRK) Second Quarter 2025 Results Key Financial Results Revenue: €5.26b (down 1.8% from 2Q 2024). Net income: €652.0m (up 7.4% from 2Q 2024). Profit margin: 12% (up from 11% in 2Q 2024). The increase in margin was driven by lower expenses. EPS: €1.50 (up from €1.40 in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Merck KGaA Revenues and Earnings Miss Expectations Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) also missed analyst estimates by 18%. Looking ahead, revenue is forecast to grow 3.9% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Pharmaceuticals industry in Germany. Performance of the German Pharmaceuticals industry. The company's share price is broadly unchanged from a week ago. Balance Sheet Analysis While earnings are important, another area to consider is the balance sheet. See our latest analysis on Merck KGaA's balance sheet health. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

🗞️Today's headlines: Barça party at the Gamper, injuries and more
🗞️Today's headlines: Barça party at the Gamper, injuries and more

Yahoo

time2 minutes ago

  • Yahoo

🗞️Today's headlines: Barça party at the Gamper, injuries and more

The week leading up to the start of the League kicks off with teams finalizing their preseason preparations. Barça's festival against Fábregas' Como, Camavinga's recent injury, or Isco's condition are just some of the topics with which the sports press starts this Monday before the League's MARCA Diario AS Mundo Deportivo Diario SPORT Superdeporte Estadio Deportivo L'Esportiu This article was translated into English by Artificial Intelligence. You can read the original version in 🇪🇸 here. 📸 JOSEP LAGO - AFP or licensors

Who can challenge Liverpool?
Who can challenge Liverpool?

Yahoo

time2 minutes ago

  • Yahoo

Who can challenge Liverpool?

Chelsea's 3-0 win in the final of the Club World Cup against European champions Paris St-Germain was a statement that they are a force to be reckoned with. Manager Enzo Maresca has united a group of players who cost up to £1.4bn, according to the club's own accounts, and although the starting XIs were the youngest ever to play out a Premier League season last year, they appear to be good enough to win titles. Among the star players are Cole Palmer, Enzo Fernandez, Moises Caicedo and Marc Cucurella but the Blues have also added Joao Pedro, Liam Delap, Jamie Gittens, Estevao Willian and Jorrel Hato this summer to cope with the increased workload of returning to the Champions League next season. Internally, Chelsea have again set a top-four finish in the league as the main target, but defender Levi Colwill is among those who suggest they are ready to win the Premier League or Champions League as early as next season. Read about the other contenders

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store